Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Silverberg

Showing results (121-130 of 228) with videos related to

Pageof 23
Sort By:
Inflammatory Bowel Diseases|October 20, 2015
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel DiseaseMark M Sasaki, Andrew D Skol, Eric A Hungate, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
The American Journal of Gastroenterology|December 12, 2012
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics ConsortiumMark Lazarev, Chengrui Huang, Alain Bitton, et al.
Clinical and Translational Gastroenterology|January 17, 2014
Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel diseaseSandeep S Dhillon, Lucas A Mastropaolo, Ryan Murchie, et al.
Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Frontiers in Immunology|August 21, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell populationTiago S Medina, Alex Murison, Michelle Smith, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.
Pageof 23

Showing results (121-130 of 228) with videos related to

Sort By:
Pageof 23
Inflammatory Bowel Diseases|October 20, 2015
Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel DiseaseMark M Sasaki, Andrew D Skol, Eric A Hungate, et al.
Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.
Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.
The American Journal of Gastroenterology|December 12, 2012
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics ConsortiumMark Lazarev, Chengrui Huang, Alain Bitton, et al.
Clinical and Translational Gastroenterology|January 17, 2014
Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel diseaseSandeep S Dhillon, Lucas A Mastropaolo, Ryan Murchie, et al.
Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.
Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.
Frontiers in Immunology|August 21, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell populationTiago S Medina, Alex Murison, Michelle Smith, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.
Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.
Pageof 23